Lanreotide 30mg powder and solvent for suspension for injection vials
in short Lanreotide 30mg inj vials
previously Lanreotide 30mg injection vials and diluent
- SNOMED code
36037811000001100
previously327380000- Code valid from
- Named
- Active compound
- Lanreotide
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- ✅ Yes
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Lanreotide acetate, ID: 395765000
— 30 mg
based on base substance
- Form & Route
- suspensioninjection.intramuscular
Powder and solvent for suspension for injection, Intramuscular - Controlled drug
- No Controlled Drug Status
Products
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd)
in short Somatuline LA 30mg inj vials
previously Somatuline LA 30mg injection vials and diluent
Somatuline LA 30mg powder and solvent for suspension for injection vials
- SNOMED code
4149011000001101- Named
- Supplier
- Ipsen Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- Not available
- Licensed route
- Intramuscular
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial4149611000001108 ref. pack |
Discontinued
Legal category: POM | 5036611000004End: 3582186001271 | No Price Available previously: £323 | • Personally Administered |
| — |
Reference packs
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial
- SNOMED code
4148111000001107- Quantity and unit
- 1 vial
- Packs